Merit Medical CLO buys 2,000 shares in 401(k)
Merit Medical Systems’ chief legal officer Brian G. Lloyd reported an insider purchase of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Merit Medical Systems’ chief legal officer Brian G. Lloyd reported an insider purchase of company stock. On May 7, 2026, an entity described as a 401(k) plan bought 2,000 shares of common stock at $62.625 per share, recorded as indirect ownership.
Following this transaction, Lloyd’s filing shows 62,132 shares of common stock held directly, plus the 2,000 shares held through the 401(k) plan. He also retains several blocks of non-qualified stock options to buy common shares, with exercise prices ranging from $37.71 to $70.58 and expirations between 2027 and 2030.
Insider Trade Summary
Net Buyer: 2,000 shares
Net Buy
6 txns
Insider
Lloyd Brian G.
Role
CHIEF LEGAL OFFICER, SECRETARY
Bought
2,000 shs ($125K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, No Par Value | 2,000 | $62.625 | $125K |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Common Stock, No Par Value | -- | -- | -- |
Holdings After Transaction:
Common Stock, No Par Value — 2,000 shares (Indirect, By 401 (k) plan);
Non-qualified stock options (right to buy) — 48,073 contracts (Direct);
Common Stock, No Par Value — 62,132 shares (Direct)
Footnotes (4)
- F1. Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
- F2. Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
- F3. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- F4. Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Key Figures
Open-market purchase: 2,000 shares at $62.625
Direct common shares: 62,132 shares
Indirect 401(k) shares: 2,000 shares
+4 more
7 metrics
Open-market purchase
2,000 shares at $62.625
Common Stock bought via 401(k) on May 7, 2026
Direct common shares
62,132 shares
Common Stock held directly after reported transaction
Indirect 401(k) shares
2,000 shares
Common Stock held indirectly by 401(k) plan
Option block 1
13,576 underlying shares at $70.58
Non-qualified stock options expiring Feb 28, 2030
Option block 2
8,094 underlying shares at $65.03
Non-qualified stock options expiring Feb 28, 2029
Option block 3
9,681 underlying shares at $56.25
Non-qualified stock options expiring Mar 19, 2028
Option block 4
16,722 underlying shares at $37.71
Non-qualified stock options expiring Feb 26, 2027
Key Terms
Non-qualified stock options (right to buy), open-market purchase, 401 (k) plan, exercise price, +1 more
5 terms
Non-qualified stock options (right to buy) financial
"security_title: Non-qualified stock options (right to buy)"
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
401 (k) plan financial
"nature_of_ownership: By 401 (k) plan"
exercise price financial
"conversion_or_exercise_price: 37.7100, 56.2500, 65.0300, 70.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date values from 2027-02-26 to 2030-02-28"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MMSI’s chief legal officer report on this Form 4?
The Form 4 shows a purchase of 2,000 shares of Merit Medical Systems common stock at $62.625 per share. The shares are held indirectly through a 401(k) plan, indicating additional personal exposure to the company’s stock.
What stock options for MMSI does the chief legal officer retain?
The filing lists several non-qualified stock options to buy MMSI common stock. These include grants with exercise prices such as $37.71, $56.25, $65.03, and $70.58, with expiration dates ranging from 2027 through 2030.
Is the MMSI Form 4 transaction a buy or sell by the insider?
The Form 4 reports an open-market purchase coded “P”, reflecting a buy transaction. It records the acquisition of 2,000 shares of Merit Medical common stock at $62.625 per share through a 401(k) plan arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates